Tag Archives: Weiner

Could DNA Vaccines Be Reaching Their Prime?

In his talk at the 15th Annual Conference on Vaccine Research about advances in vaccine discovery, David Weiner, chair of the gene therapy and vaccines program at the University of Pennsylvania, recalled that it has been about two decades since the “public coming out” of DNA-based vaccination in AIDS research.

Dr. David B. Weiner awarded AAAS distinction for his pioneering research of synthetic DNA vaccines

Inovio Pharmaceuticals, Inc. (NYSE Amex: INO) announced today that David B. Weiner, Ph.D., Professor, Department of Pathology & Laboratory Medicine, University of Pennsylvania, and Chairman of Inovio’s Scientific Advisory Board, has been elected a fellow in the American Association for the Advancement of Science (AAAS). Dr. Weiner, often called the “father of synthetic DNA vaccines,” is being honored for his pioneering and enabling discoveries in the area of synthetic DNA vaccines and promoting the nascent field of research during its early stages. Dr. Weiner was recognized at the Fellows Forum held February 18th during the AAAS Annual Meeting in Vancouver, Canada.